Liraglutide is Safe and Effective in Mild or Moderate Renal Impairment: the Association of British Clinical Diabetologists (ABCD) Nationwide Liraglutide Audit

Thong KY¹, Walton C², Ryder REJ¹, ABCD Nationwide Liraglutide Audit Contributors

¹City Hospital, Birmingham, UK

²Hull Royal Infirmary, Hull, UK

Insulin Necessity is Better than Diabetes Duration in Predicting Liraglutide Treatment Response: the Association of British Clinical Diabetologists (ABCD) Nationwide Liraglutide Audit

Thong KY¹, Walton C², Ryder REJ¹, ABCD Nationwide Liraglutide Audit Contributors

¹City Hospital, Birmingham, UK

²Hull Royal Infirmary, Hull, UK

Switching exenatide or gliptins to liraglutide in the Association of British Clinical Diabetologists (ABCD) nationwide liraglutide audit

K.Y. Thong¹, K. Darzy², M.L. Cull¹, A.P. Mills¹, R.E.J. Ryder¹, ABCD nationwide exenatide and liraglutide audit contributors

¹City Hospital, Diabetes, Birmingham, UK

²Queen Elizabeth II Hospital, Diabetes, Welwyn Garden City, UK

Factors associated with HbA1c and weight changes in the Association of British Clinical Diabetologists (ABCD) nationwide GLP-1 agonists audit

K.Y. Thong¹, R.E.J. Ryder¹, C. Walton², ABCD nationwide exenatide and liraglutide audit contributors

¹City Hospital, Diabetes, Birmingham, UK

²Hull Royal Infirmary, Diabetes, Hull, UK

The Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

R.E.J. Ryder¹, K.Y. Thong¹, M.L. Cull¹, A.P. Mills¹, C. Walton², ABCD nationwide exenatide and liraglutide audit contributors

¹Diabetes, City Hospital, Birmingham, UK

²Diabetes, Hull Royal Infirmary, Hull, UK

Factors associated with HbA1c and weight changes at 6 months in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audit

C. Walton¹, R.E.J. Ryder², M.L. Cull², A.P. Mills², K.Y. Thong², ABCD nationwide exenatide and liraglutide audit contributors

¹Diabetes, Hull Royal Infirmary, Hull, UK

²Diabetes, City Hospital, Birmingham, UK

Factors associated with HbA1c and Weight changes at 6 months in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audit

C. Walton¹, R.E.J. Ryder², M.L. Cull², A.P. Mills², K.Y. Thong², ABCD nationwide exenatide and liraglutide audit contributors;

¹Diabetes, Hull Royal Infirmary, Hull, UK

²Diabetes, City Hospital, Birmingham, UK

The Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

R.E.J. Ryder¹, K.Y. Thong¹, M.L. Cull¹,  A.P. Mills¹, C. Walton², ABCD nationwide exenatide and liraglutide audit contributors;

¹Diabetes, City Hospital, Birmingham, UK

²Diabetes, Hull Royal Infirmary, Hull, UK

Early impact of liraglutide in routine clinical use (ABCD nationwide liraglutide audit) on cardiovascular risk (UKPDS risk engine). Diabetologia 2018, Vol.61 Supplement1: Abstract 747

C. Walton¹, S. Kassim², R. Harper³, P. McDonald³, U. Brennan³, J. Harding³, T. Htay⁴, R. Nayar⁵, A. Pernet⁶, S. Rowles⁷, K. Adamson⁸, K.Y. Thong⁹, R.E.J. Ryder¹⁰

¹Hull Royal Infirmary, Hull, UK